
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.01 | 1.22 | 0.21 |
Shares | 98.99 | 99.01 | 0.02 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.46 | 19.70 |
Price to Book | 3.76 | 3.89 |
Price to Sales | 2.05 | 2.23 |
Price to Cash Flow | 12.45 | 14.91 |
Dividend Yield | 2.15 | 1.49 |
5 Years Earnings Growth | 7.93 | 10.16 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.54 | 94.29 |
Basic Materials | 0.39 | 1.96 |
Consumer Defensive | 0.04 | 3.27 |
Financial Services | 0.03 | 7.59 |
Number of long holdings: 181
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.29 | 762.33 | +3.01% | |
J&J | US4781601046 | 5.33 | 167.33 | +1.57% | |
AbbVie | US00287Y1091 | 4.66 | 195.22 | +3.28% | |
UnitedHealth | US91324P1021 | 3.96 | 237.77 | -4.72% | |
Abbott Labs | US0028241000 | 3.27 | 127.29 | +0.87% | |
Novartis | CH0012005267 | 3.24 | 93.11 | -1.15% | |
Roche Holding Participation | CH0012032048 | 3.22 | 252.80 | -1.67% | |
Novo Nordisk B | DK0062498333 | 3.11 | 315.6 | +2.19% | |
Intuitive Surgical | US46120E6023 | 2.77 | 483.12 | +0.42% | |
Merck&Co | US58933Y1055 | 2.77 | 79.29 | +1.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.1B | -9.46 | 8.17 | 13.30 | ||
Legal General US Index Trust C Dist | 971.15M | -9.51 | 8.16 | 13.29 | ||
International Index Trust I Acc | 1.35B | -0.17 | 13.97 | 12.34 | ||
International Index Trust I Dist | 294.36M | -0.11 | 14.00 | 12.34 | ||
International Index Trust R Acc | 38.26M | -0.30 | 13.56 | 11.80 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review